Adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins.

Abstract

BACKGROUND In everyday practice, adherence to preventive medication for cardiovascular disease (CVD) is lower than in clinical trials and appears to decline to approximately 50% by about 5 years. The UK body for the evaluation of health technologies, NICE, currently recommends that persons with a >20% 10-year risk of incident cardiovascular disease receive… (More)
DOI: 10.1136/jech.2009.091033

Topics

Cite this paper

@article{Shroufi2010AdherenceAC, title={Adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins.}, author={Amir Shroufi and Jenifer Powles}, journal={Journal of epidemiology and community health}, year={2010}, volume={64 2}, pages={109-13} }